search
Back to results

Sex Selection of Human Spermatozoa

Primary Purpose

Infertility, IVF

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Sperm Sorting
Sponsored by
Weill Medical College of Cornell University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Infertility

Eligibility Criteria

18 Years - 89 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Couples undergoing infertility treatment with IVF or insemination seeking gender specific offspring for medical and non medical reasons

Exclusion Criteria:

  • Severe male factor

Sites / Locations

  • Center for Reproductive Medicine- Weill Cornell MedicineRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Sperm sorting

Arm Description

Selection of gender specific spermatozoa using a multilayer density gradient

Outcomes

Primary Outcome Measures

Rate of gender bearing spermatozoa after 4-layer density gradient
Rate of embryos of the desired gender in couples
Rate of offspring of the desired gender in couples

Secondary Outcome Measures

Full Information

First Posted
August 11, 2022
Last Updated
August 22, 2023
Sponsor
Weill Medical College of Cornell University
search

1. Study Identification

Unique Protocol Identification Number
NCT05500573
Brief Title
Sex Selection of Human Spermatozoa
Official Title
Sex Selection of Human Spermatozoa
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
November 6, 2013 (Actual)
Primary Completion Date
December 31, 2025 (Anticipated)
Study Completion Date
December 31, 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Weill Medical College of Cornell University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study aims to demonstrate a reliable method of selecting gender specific sperm. X-bearing spermatozoa and Y-bearing spermatozoa will be identified from the density gradient layers. The selected gender specimen will then be utilized for assisted reproductive fertilization- in vitro fertilization or intrauterine insemination which are routine standard of care procedures.
Detailed Description
The study aim is to test a simple, reliable, and inexpensive method to attempt selection of gender specific spermatozoa. Couples will undergo evaluation and treatment according to the standard clinic procedures. Sperm samples provided for infertility treatment will be further analyzed routine semen analysis for volume, concentration, mobility and morphology. Sperm samples will be provided by consenting males undergoing infertility treatment. A multilayer density gradient will be performed utilizing an FDA approved solution, Enhance-S Plus Cell Isolation Media (Vitrolife, San Diego, CA). This density gradient is also used for standard semen preparation for intrauterine insemination. X-bearing spermatozoa and Y-bearing spermatozoa will be identified from the density gradient fractions. Sperm suspensions will be smeared on slides for FISH analysis using centromeric probes for chromosomes 18, X, and Y. The ratio of X- to Y- chromosome bearing spermatozoa will be assessed as a percentage on at least 200 cells per slide. Aneuploid cells and those without signals will be omitted. Unselected fractions of each sample will serve as controls. The rate of X-bearing spermatozoa after 4-layer density gradient will be calculated. After thorough counseling, the selected preconception gender specimen will then be utilized for assisted reproductive fertilization- in vitro fertilization with or without intracytoplasmic sperm injection (ICSI) or intra uterine insemination which are routine standard of care procedures.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Infertility, IVF

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Sperm ejaculates are processed by an in-house protocol that utilized a multilayer density gradient comprised of four concentrations: 20%, 40%, 60%, and 90% to attempt selection of gender specific spermatozoa.
Masking
None (Open Label)
Allocation
N/A
Enrollment
2000 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Sperm sorting
Arm Type
Experimental
Arm Description
Selection of gender specific spermatozoa using a multilayer density gradient
Intervention Type
Procedure
Intervention Name(s)
Sperm Sorting
Other Intervention Name(s)
Sperm Sex Selection
Intervention Description
Selection of gender specific spermatozoa using a multilayer density gradient solution
Primary Outcome Measure Information:
Title
Rate of gender bearing spermatozoa after 4-layer density gradient
Time Frame
8 years
Title
Rate of embryos of the desired gender in couples
Time Frame
8 years
Title
Rate of offspring of the desired gender in couples
Time Frame
8 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
89 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Couples undergoing infertility treatment with IVF or insemination seeking gender specific offspring for medical and non medical reasons Exclusion Criteria: Severe male factor
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Rodriq Stubbs, MS, NP
Phone
646-962-3276
Email
res2011@med.cornell.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Stephanie Cheung
Phone
646-962-8448
Email
stc3001@med.cornell.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gianpiero Palermo, MD, PhD
Organizational Affiliation
Weill Medical College of Cornell University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Center for Reproductive Medicine- Weill Cornell Medicine
City
New York
State/Province
New York
ZIP/Postal Code
10021
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rodriq Stubbs, MS, NP
Phone
646-962-3276
Email
res2011@med.conrell.edu
First Name & Middle Initial & Last Name & Degree
Stephanie Cheung
Phone
646-962-8448
Email
cts3001@med.conrell.edu

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Sex Selection of Human Spermatozoa

We'll reach out to this number within 24 hrs